Inventor
Nan-Horng Lin
Inventor
Vernon Hills, IL, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
A61KPreparations for medical, dental or toiletry purposes11%
C12NMicroorganisms or enzymes7%
C12YEnzymes7%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture6%
C07KPeptides5%
C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds3%
H01BCables3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
10,745,360Quinoxaline compounds, method for preparing the same and use thereof202010,538,592Antibodies, binding fragments, and methods of use202010,407,673Methods for glycoprotein remodeling using endoglycosidase mutants201910,377,990Viral resistant cells and uses thereof201910,000,747Endoglycosidase mutants for glycoprotein remodeling and methods of using it20189,670,271'Production of recombinant proteins with simple glycoforms'20179,376,484'Production of recombinant proteins with simple glycoforms'20169,340,558'Filamin a binding anti-inflammatory and analgesic'20169,321,762'Quinazoline compounds, method for preparing the same and use thereof'20169,062,338'Method of producing human-like glycosylation pattern using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase'20158,980,583'Cells deficient in CMP-N-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase'20158,653,068'Filamin A binding anti-inflammatory and analgesic'20148,614,324'Filamin A binding anti-inflammatory and analgesic'20138,580,809'Filamin A-binding anti-inflammatory analgesic'20138,580,808'Filamin A-binding anti-inflammatory analgesic'20138,148,384'Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics'20127,956,185'Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases'20117,456,169'Heterocyclic kinase inhibitors'20087,323,570'Farnesyltransferase inhibitors'20087,320,986'Fused tri and tetra-cyclic pyrazole kinase inhibitors'20087,211,595'Farnesyltransferase inhibitors'20077,163,939'Macrocyclic kinase inhibitors'20077,056,925'Urea kinase inhibitors'20066,797,825'Protein kinase inhibitors'20046,656,958'Substituted pyridine compounds useful for controlling chemical synaptic transmission'20036,437,138'3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission'20026,403,575'3-Pyridyl enantiomers and their use as analgesics'20026,133,253'3-Pyridyl enantiomers and their use as analgesics'20006,127,386'3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission'20006,001,849'Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission'19995,948,793'3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release'19995,914,328'Heterocyclic ether compounds useful in controlling neurotransmitter release'19995,733,912'7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission'19985,629,325'3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission'19975,559,242'Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles'19965,516,912'Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(s)-pyrrolidinyl)isoxazoles'19965,508,418'Intermediates for the preparation of enantiomerically-pure-3-methyl-5-(1-C1-C3-alkyl)-2-pyrrolidinyl)isoxazol e'19965,472,958'2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function'19955,424,444'Method of preparing enantiomerically-pure 3-methyl-5-(1-alkyl-2(S)-pyrrolidinyl) isoxazoles'19955,409,946'Isoxazole, isothiazole and pyrazole compounds that enhance cognitive function'1995RE034919'Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers'19955,300,637'2-benzothiazolyl tetrazolium salt indicators'19945,278,176'Nicotine derivatives that enhance cognitive function'19945,126,275'Analytical method using tetrazolium salt indicators having a reflectance plateau'19925,068,355'Semi-conducting oligomers and method relating thereto'19915,021,586'Dithiophenylpyrrole derivative monomers for preparing semi-conducting polymers'1991Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1991–1995Patents assigned to MILES INC (5)· patent assignee history
1991–1995Based in Elkhart, IN, US· patent location history
1992–2000Based in Mundelein, IL, US· patent location history
1994–2012Patents assigned to ABBOTT LAB (26)· patent assignee history
2002–2020Based in Vernon Hills, IL, US· patent location history
2012–2016Patents assigned to LIN NAN-HORNG (6)· patent assignee history
2013–2016Patents assigned to BLASKO ANDREI (5)· patent assignee history
2015–2019Patents assigned to SIGMA ALDRICH CO LLC (5)· patent assignee history
2015–2019Based in St. Louis, MO, US· patent location history
2016–2020Based in New Taipei, TW· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBOTT LAB | 26 | 1994–2012 |
| LIN NAN-HORNGself | 6 | 2012–2016 |
| BLASKO ANDREI | 5 | 2013–2016 |
| MILES INC | 5 | 1991–1995 |
| SIGMA ALDRICH CO LLC | 5 | 2015–2019 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vernon Hills, Illinois, US | 20 | 2002–2020 |
| Mundelein, Illinois, US | 16 | 1992–2000 |
| St. Louis, MO, US | 5 | 2015–2019 |
| Elkhart, IN, US | 3 | 1991–1995 |
| New Taipei, TW | 2 | 2016–2020 |